Square or Rectangle Cuvettes and Cells
Med Vet International Meniscus Probe, 2mm (nerve hook), J0710N
Visualization of the caudal horns of the meniscus can be a challenge. Often the process of exposing the caudal horn can result in distortions. A normal meniscus can look damaged or a "bucket handle" tear can sit back and look normal. It is helpful to gently probe the meniscus to establish its true condition. Dimensions refer to length of tip. Use 1mm in dogs <30kg and for dogs >30kg use a 2mm.
Med Vet International Distal Femur Plate, J0428P, 50mm, Left, 2mm Holes, Each
Fracture repair in the Supracondylar femur region can be challenging, particularly in medium to large dogs. Forces acting on this region are complex and must be neutralized. In addition, the bone shape makes the use of standard plates virtually impossible. JorVet supracondylar plates are designed to fit the distal femur with a minimum of further contouring. These plates are curved on the distal end to follow the natural bone curvature. The plate thickness tapers distally from 1.5mm to 1mm on 2mm plates. In cats and small dogs supracondylar fractures are usually simple and transverse, hence the 2mm plates are relatively lightweight. Medium and larger dogs typically have more complex fractures at this site with multiple fragments, requiring much more plate support. Our 2.7 and 3.5 plate’s shape and strength reflect this. Apply the plate when possible to the lateral surface of the femur.
Genscript Corporation CLEC12A/MICL/CLL-1 His Cynom
CLEC12A has recently been identified as an antigen expressed on leukemic stem cells and leukemic blasts Given the fact that this expression profile seems stable throughout diagnosis treatment and relapse on leukemic blasts and leukemic stem cells CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML
Genscript Corporation CLEC12A/MICL/CLL-1 hFc Chimera
CLEC12A has recently been identified as an antigen expressed on leukemic stem cells and leukemic blasts Given the fact that this expression profile seems stable throughout diagnosis treatment and relapse on leukemic blasts and leukemic stem cells CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML